Article Text

Download PDFPDF
Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB
  1. Yasushi Mabuchi, MD, PhD,
  2. Tamaki Yahata, MD,
  3. Aya Kobayashi, MD,
  4. Yuko Tanizaki, MD, PhD,
  5. Michihisa Shiro, MD,
  6. Nami Ota, MD,
  7. Shigetaka Yagi, MD,
  8. Sawako Minami, MD, PhD and
  9. Kazuhiko Ino, MD, PhD
  1. Department of Obstetrics and Gynecology, School of Medicine, Wakayama Medical University, Kimiidera, Wakayama, Japan.
  1. Address correspondence and reprint requests to Yasushi Mabuchi, MD, PhD, Department of Obstetrics and Gynecology, Wakayama Medical University, School of Medicine, 811-1, Kimiidera, Wakayama, 641-0012, Japan. E-mail: booyan{at}wakayama-med.ac.jp.

Abstract

Objective The aim of this study was to clarify the clinicopathologic factors of stages IB to IIB cervical adenocarcinoma.

Methods Several clinicopathologic factors were compared between 35 patients who underwent radical hysterectomy and pelvic lymphadenectomy due to cervical adenocarcinoma stages IB to IIB and 77 patients with squamous cell carcinoma (SCC).

Results In patients with adenocarcinoma, univariate analysis demonstrated that International Federation of Gynecology and Obstetrics stage, tumor size, and lymphovascular space invasion were significantly associated with progression-free survival (PFS), whereas FIGO stage, lymphovascular space invasion, and lymph node metastasis were significantly associated with overall survival (OS). However, multivariate analysis revealed that FIGO stage was the only significant factor for PFS in patients with adenocarcinoma. In patients with SCC, univariate analysis demonstrated that FIGO stage and lymph node metastasis were significantly associated with PFS, whereas FIGO stage, lymphovascular space invasion, and lymph node metastasis were significantly associated with OS. Multivariate analysis revealed that lymph node metastasis was the only significant factor for PFS and OS in patients with SCC. In 26 patients who were positive for high-risk human papillomavirus (HPV), including both adenocarcinoma and SCC patients, univariate and multivariate analyses revealed that HPV18 was significantly associated with poorer PFS compared with non-HPV18. There was a significant difference in distribution of HPV genotype between adenocarcinoma and SCC.

Conclusions Careful treatment may be necessary for the patients with lymphovascular space invasion in early-stage cervical adenocarcinoma. The presence of HPV18 may have an influence on the prognosis of early-stage cervical carcinoma.

  • Adenocarcinoma
  • Cervical carcinoma
  • Clinicopathologic factor
  • Human papillomavirus

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.